859P The influence of hematologic malignancies on response to immune checkpoint inhibition in patients with advanced melanoma

Autor: O.J. van Not, F. Van Den Eertwegh, J.B.A.G. Haanen, R.S. van Rijn, M. Aarts, F. Van den Berkmortel, C.U. Blank, M. Boers-Sonderen, J.W.B. de Groot, G. Hospers, E. Kapiteijn, M.M. De Meza, D. Piersma, M. Stevense-den Boer, A.A.M. Van der Veldt, G. Vreugdenhil, M. Wouters, W.A.M. Blokx, K.P.M. Suijkerbuijk

Publikováno v: Annals of Oncology. 33:S942-S943

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d92272e1eea9ab7f57d3d24fc6492a04
https://doi.org/10.1016/j.annonc.2022.07.985

Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs

Autor: Gap Hospers, M Franken, A.C.J. van Akkooi, H.M. Westgeest, Ellen Kapiteijn, Marye J Boers-Sonderen, R van Rijn, Mieke J. Aarts, A.J.M. van den Eertwegh, F van den Berkmortel, J.W.B. de Groot, Michel W.J.M. Wouters, B Leeneman, C.A. Uyl-de Groot, Karijn P M Suijkerbuijk, J.B.A.G. Haanen, A.A.M. Van der Veldt, Djura Piersma

Publikováno v: ESMO Open, 6(6):100320. BMJ PUBLISHING GROUP
ESMO Open, 6(6):100320. BMJ Publishing Group
Esmo Open, 6, 6
Franken, M G, Leeneman, B, Aarts, M J B, van Akkooi, A C J, van den Berkmortel, F W P J, Boers-Sonderen, M J, van den Eertwegh, A J M, de Groot, J W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, van der Veldt, A A M, Westgeest, H M, Wouters, M W J M, Haanen, J B A G & Uyl-de Groot, C A 2021, ' Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs ', ESMO OPEN, vol. 6, no. 6, 100320 . https://doi.org/10.1016/j.esmoop.2021.100320
ESMO OPEN, 6(6):100320. BMJ Publishing Group
Esmo Open, 6
ESMO Open

Background The objective of this study was to evaluate trends in survival and health care costs in metastatic melanoma in the era of targeted and immunotherapeutic drugs. Materials and methods Data on survival and health care resource use were retrie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea39d269770e5d944e6d16f2b5d3805c
https://research.rug.nl/en/publications/7a2faa86-1f60-41de-bb5a-6d3d09d52114

Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study

Autor: E.M. Wijnen, R.J.A. Van Moorselaar, I.M. van Oort, C.A. Hulsbergen-van de Kaa, H. Jansen, G J L H van Leenders, Floris J. Pos, B.P. Wijsman, Jurgen J. Fütterer, Ruben Cremers, Lambertus A. Kiemeney, Katja K.H. Aben, Maarten C.C.M. Hulshof, G. van Andel, Paul Hamberg, D.M. Somford, Martijn B. Busstra, F. van den Berkmortel, Robin W.M. Vernooij

Publikováno v: Vernooij, R W M, Cremers, R G H M, Jansen, H, Somford, D M, Kiemeney, L A, van Andel, G, Wijsman, B P, Busstra, M B, van Moorselaar, R J A, Wijnen, E M, Pos, F J, Hulshof, M C C M, Hamberg, P, van den Berkmortel, F, Hulsbergen-van de Kaa, C A, van Leenders, G J L H, Fütterer, J J, van Oort, I M & Aben, K K H 2020, ' Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer : A nationwide observational study ', Urologic Oncology, vol. 38, no. 9, pp. 735.e17-735.e25 . https://doi.org/10.1016/j.urolonc.2020.05.022
Urologic Oncology-Seminars and Original Investigations, 38, 735.e17-735.e25
Urologic Oncology, 38(9), 735.e17-735.e25. Elsevier Inc.
Urologic oncology, 38(9), 735.e17-735.e25. Elsevier Inc.
Urologic Oncology-Seminars and Original Investigations, 38(9). Elsevier Inc.
Urologic Oncology-Seminars and Original Investigations, 38, 9, pp. 735.e17-735.e25

BACKGROUND: Although urinary adverse events after treatment of prostate cancer (CaP) are common, population-based studies on functional outcomes are scarce. The aim of this study is to evaluate the occurrence of urinary incontinence (UI) and erectile

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::121a2b747d1109a51204e806f2d34214
https://pubmed.ncbi.nlm.nih.gov/35654644

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Real-World Outcomes of Ipilimumab in Patients with Advanced Melanoma in The Netherlands

Autor: Maureen J.B. Aarts, R van Rijn, M Schouwenburg, D Piersma, J.S. van der Hoeven, Marieke W. J. Louwman, G. Vreugdenhil, Rutger H. T. Koornstra, A Jochems, F van den Berkmortel, Michel W.J.M. Wouters, A.J.M. van den Eertwegh, Wim H. J. Kruit, B Leeneman, Geke A. P. Hospers, Gerard Groenewegen, H Kapiteijn, J.W.B. de Groot, A.C.J. van Akkooi, M Franken, A.J. ten Tije, M van Zeijl, J.B.A.G. Haanen, C Uyl de Groot

Publikováno v: Value in Health. 19:A708-A709

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fb2a99432380e5ad3ee80b71cc01bc40
https://doi.org/10.1016/j.jval.2016.09.2077